Cargando…
Discrepancy between financial disclosures of authors of clinical practice guidelines and reports by industry
There is a substantial effort to increase the accuracy of conflicts of interest (COI) reporting, and reduce the influence of COI between physicians and industry, especially as it relates to clinical practice guidelines. We used the newly implemented Open Payments dataset to evaluate the accuracy of...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266162/ https://www.ncbi.nlm.nih.gov/pubmed/28079800 http://dx.doi.org/10.1097/MD.0000000000005711 |
_version_ | 1782500418628091904 |
---|---|
author | Andreatos, Nikolaos Zacharioudakis, Ioannis M. Zervou, Fainareti N. Muhammed, Maged Mylonakis, Eleftherios |
author_facet | Andreatos, Nikolaos Zacharioudakis, Ioannis M. Zervou, Fainareti N. Muhammed, Maged Mylonakis, Eleftherios |
author_sort | Andreatos, Nikolaos |
collection | PubMed |
description | There is a substantial effort to increase the accuracy of conflicts of interest (COI) reporting, and reduce the influence of COI between physicians and industry, especially as it relates to clinical practice guidelines. We used the newly implemented Open Payments dataset to evaluate the accuracy of COI disclosures of authors of clinical practice guidelines that were either newly published or revised within 2014 and were included in the National Guideline Clearinghouse (NGC) website (maintained by the U.S. Department of Health and Human Services). Authors were considered as having inaccurate COI disclosure if they had not reported all companies from which they had received funds >$5000 in the 12 months preceding the guideline's publication. We identified 223 guidelines that were either newly published (109/223; 48.9%) or revised (114/223; 51.1%) within 2014 and were included in the NGC website. Among the 1329 guideline authors with available Open Payments data, 523 received >$5000 from at least 1 healthcare-associated entity. However, only 56 out of the 523 authors (10.7%) were found to have accurate COI disclosure. The percentage of authors with accurate COI disclosure in revised guidelines was significantly lower than in newly published guidelines (6.8% vs 14.3%; P < 0.01) and was also found to differ between specialties. Furthermore, authors were less likely to inaccurately disclose “research payments” (37/49, 75.5%) compared to “general payments” (488/559, 87.3%, P = 0.02) as well as “other/associated research funding” (430/506, 85.0%, P = 0.08). No statistically significant association was detected between funding amount and disclosure accuracy. The majority of guideline authors lacked significant COIs, but among authors that received significant funds from at least 1 healthcare-associated entity the frequency of accurate disclosure was low. These findings indicate that the current process of disclosing COIs may be suboptimal and a proactive approach should be adopted in order to minimize COI reporting discrepancies. Furthermore, every effort should be undertaken to ensure the completeness and accuracy of the data recorded in the Open Payments database. |
format | Online Article Text |
id | pubmed-5266162 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-52661622017-02-07 Discrepancy between financial disclosures of authors of clinical practice guidelines and reports by industry Andreatos, Nikolaos Zacharioudakis, Ioannis M. Zervou, Fainareti N. Muhammed, Maged Mylonakis, Eleftherios Medicine (Baltimore) 6600 There is a substantial effort to increase the accuracy of conflicts of interest (COI) reporting, and reduce the influence of COI between physicians and industry, especially as it relates to clinical practice guidelines. We used the newly implemented Open Payments dataset to evaluate the accuracy of COI disclosures of authors of clinical practice guidelines that were either newly published or revised within 2014 and were included in the National Guideline Clearinghouse (NGC) website (maintained by the U.S. Department of Health and Human Services). Authors were considered as having inaccurate COI disclosure if they had not reported all companies from which they had received funds >$5000 in the 12 months preceding the guideline's publication. We identified 223 guidelines that were either newly published (109/223; 48.9%) or revised (114/223; 51.1%) within 2014 and were included in the NGC website. Among the 1329 guideline authors with available Open Payments data, 523 received >$5000 from at least 1 healthcare-associated entity. However, only 56 out of the 523 authors (10.7%) were found to have accurate COI disclosure. The percentage of authors with accurate COI disclosure in revised guidelines was significantly lower than in newly published guidelines (6.8% vs 14.3%; P < 0.01) and was also found to differ between specialties. Furthermore, authors were less likely to inaccurately disclose “research payments” (37/49, 75.5%) compared to “general payments” (488/559, 87.3%, P = 0.02) as well as “other/associated research funding” (430/506, 85.0%, P = 0.08). No statistically significant association was detected between funding amount and disclosure accuracy. The majority of guideline authors lacked significant COIs, but among authors that received significant funds from at least 1 healthcare-associated entity the frequency of accurate disclosure was low. These findings indicate that the current process of disclosing COIs may be suboptimal and a proactive approach should be adopted in order to minimize COI reporting discrepancies. Furthermore, every effort should be undertaken to ensure the completeness and accuracy of the data recorded in the Open Payments database. Wolters Kluwer Health 2017-01-13 /pmc/articles/PMC5266162/ /pubmed/28079800 http://dx.doi.org/10.1097/MD.0000000000005711 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 |
spellingShingle | 6600 Andreatos, Nikolaos Zacharioudakis, Ioannis M. Zervou, Fainareti N. Muhammed, Maged Mylonakis, Eleftherios Discrepancy between financial disclosures of authors of clinical practice guidelines and reports by industry |
title | Discrepancy between financial disclosures of authors of clinical practice guidelines and reports by industry |
title_full | Discrepancy between financial disclosures of authors of clinical practice guidelines and reports by industry |
title_fullStr | Discrepancy between financial disclosures of authors of clinical practice guidelines and reports by industry |
title_full_unstemmed | Discrepancy between financial disclosures of authors of clinical practice guidelines and reports by industry |
title_short | Discrepancy between financial disclosures of authors of clinical practice guidelines and reports by industry |
title_sort | discrepancy between financial disclosures of authors of clinical practice guidelines and reports by industry |
topic | 6600 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266162/ https://www.ncbi.nlm.nih.gov/pubmed/28079800 http://dx.doi.org/10.1097/MD.0000000000005711 |
work_keys_str_mv | AT andreatosnikolaos discrepancybetweenfinancialdisclosuresofauthorsofclinicalpracticeguidelinesandreportsbyindustry AT zacharioudakisioannism discrepancybetweenfinancialdisclosuresofauthorsofclinicalpracticeguidelinesandreportsbyindustry AT zervoufainaretin discrepancybetweenfinancialdisclosuresofauthorsofclinicalpracticeguidelinesandreportsbyindustry AT muhammedmaged discrepancybetweenfinancialdisclosuresofauthorsofclinicalpracticeguidelinesandreportsbyindustry AT mylonakiseleftherios discrepancybetweenfinancialdisclosuresofauthorsofclinicalpracticeguidelinesandreportsbyindustry |